canagliflozin

Heavy news for diabetes! Johnson & Johnson Invokana approved for use in patients with type 2 diabetes and diabetic nephropathy

Heavy news for diabetes! Johnson & Johnson Invokana approved for use in patients with type 2 diabetes and diabetic nephropathy

March 31, 2020
 |  No Comments
 |  Drug Discovery

Johnson & Johnson (JNJ) ‘s Janssen Pharmaceuticals has announced that Health Canada has approved a new indication for the glucose-lowering drug Invokana (canagliflozin): Complementary drugs for standard care therapies for […]